(NYSE: ELV) Elevance Health's forecast annual revenue growth rate of 8.43% is not forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 8.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.31%.
Elevance Health's revenue in 2023 is $153,247,000,000.On average, 17 Wall Street analysts forecast ELV's revenue for 2023 to be $39,083,773,881,134, with the lowest ELV revenue forecast at $37,643,239,226,578, and the highest ELV revenue forecast at $42,700,281,920,258. On average, 13 Wall Street analysts forecast ELV's revenue for 2024 to be $41,937,539,226,934, with the lowest ELV revenue forecast at $39,635,085,143,216, and the highest ELV revenue forecast at $48,731,072,431,268.
In 2025, ELV is forecast to generate $47,679,247,100,830 in revenue, with the lowest revenue forecast at $42,960,257,684,644 and the highest revenue forecast at $56,463,354,226,100.